BDBM329772 Preparation of (−)-(4R)-6-(4-chlorophenyl)-1-methyl-4-{[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]methyl}-4H-[1,2,4]triazolo[4,3-a][1]benzazepine::US9663523, Example 36

SMILES CC(C)c1noc(C[C@H]2C=C(c3ccc(Cl)cc3)c3ccccc3-n3c(C)nnc23)n1

InChI Key InChIKey=JGOSSMSKHDDKJP-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 329772   

TargetBromodomain-containing protein 4(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM329772(US9663523, Example 36 | Preparation of (−)-(...)
Affinity DataIC50: 90nMAssay Description:For this purpose, a time-resolved fluorescence resonance energy transfer (TR-FRET) assay was used, which measures the binding between N-terminally Hi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent